These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 718981)

  • 21. Separation of bovine Factor VIII-related antigen (platelet aggregating factor) from bovine antihemophilic factor.
    Brown JE; Baugh RF; Sargeant RB; Hougie C
    Proc Soc Exp Biol Med; 1974 Dec; 147(3):608-11. PubMed ID: 4475426
    [No Abstract]   [Full Text] [Related]  

  • 22. Partial purification and characterization of porcine platelet-derived growth factor (PDGF).
    Poggi A; Rucinski B; James P; Holt JC; Niewiarowski S
    Exp Cell Res; 1984 Feb; 150(2):436-41. PubMed ID: 6692858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the purification and characterization of human factor 8.
    Marchesi SL; Shulman NR; Gralnick HR
    J Clin Invest; 1972 Aug; 51(8):2151-61. PubMed ID: 4626584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Is there a correlation between sugar content, thrombocyte aggregating activity and molecular size of factor VIII?].
    Furlan M; Perret BA; Beck EA
    Schweiz Med Wochenschr; 1979 Sep; 109(37):1369-70. PubMed ID: 314662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-aggregating factor and the aggregation of fixed washed platelets.
    Cooper HA; Wilkins KW; Johnson PR; Wagner RH
    J Lab Clin Med; 1977 Sep; 90(3):512-21. PubMed ID: 19545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clotting enzyme associated with the hemolymph coagulation system of horseshoe crab (Tachypleus tridentatus): its purification and characterization.
    Nakamura S; Morita T; Harada-Suzuki T; Iwanaga S; Takahashi K; Niwa M
    J Biochem; 1982 Sep; 92(3):781-92. PubMed ID: 7142117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.
    Counts RB; Paskell SL; Elgee SK
    J Clin Invest; 1978 Sep; 62(3):702-9. PubMed ID: 308512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent.
    De Marco L; Shapiro SS
    J Clin Invest; 1981 Aug; 68(2):321-8. PubMed ID: 6790574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Collagen-mediated platelet aggregation. Effects of collagen modification involving the protein and carbohydrate moieties.
    Puett D; Wasserman BK; Ford JD; Cunningham LW
    J Clin Invest; 1973 Oct; 52(10):2495-506. PubMed ID: 4354000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A platelet aggregating substance contained in xanthine oxidase preparation from cow's milk.
    Ishii H; Hiraishi S; Kazama M
    Thromb Res; 1982 Oct; 28(1):85-92. PubMed ID: 6897588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of colloidal gold granules, coated with bovine factor VIII, to human platelet membranes.
    Furlan M; Horisberger M; Perret BA; Beck EA
    Br J Haematol; 1981 Jun; 48(2):319-24. PubMed ID: 6786321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porcine Willebrand factor: a population of multimers.
    Fass DN; Knutson GJ; Bowie EJ
    J Lab Clin Med; 1978 Feb; 91(2):307-20. PubMed ID: 413873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and characterization of lipid-protein particles containing platelet factor 3 released from human platelets.
    Sandberg H; Andersson LO; Höglund S
    Biochem J; 1982 Apr; 203(1):303-11. PubMed ID: 7103943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor.
    Read MS; Shermer RW; Brinkhous KM
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4514-8. PubMed ID: 309134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings: Purification of ristocetin Willebrand factor (RWF).
    Olson JD; Fass DN; Brockway WJ; Bowie EJ; Mann KG
    Thromb Diath Haemorrh; 1975 Nov; 34(2):606. PubMed ID: 1081753
    [No Abstract]   [Full Text] [Related]  

  • 37. Isolation of bovine platelet cationic proteins which inhibit the surface-mediated activation of factor XII and prekallikrein.
    Kodama K; Kato H; Iwanaga S
    J Biochem; 1985 Jan; 97(1):139-51. PubMed ID: 3158644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on factor VIII-related protein. III. Size distribution and carbohydrate content of human and bovine factor VIII.
    Furlan M; Perret BA; Beck EA
    Biochim Biophys Acta; 1979 Aug; 579(2):325-33. PubMed ID: 534647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Separation of human factor VIII activity from the von Willebrand's antigen and ristocetin platelet aggregating activity.
    Baugh R; Brown J; Sargeant R; Hougie C
    Biochim Biophys Acta; 1974 Dec; 371(2):360-7. PubMed ID: 4433572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.